What did ExcelFin Acquisition Corp. pay for Baird Medical?

ExcelFin Acquisition Corp. acquired Baird Medical for $370.0M in 2023 (19.2x EBITDA), equivalent to 10.60x revenue. Target revenue was approximately $35.0M. Target EBITDA was approximately $19.3M.

What does Baird Medical do?

Baird Medical is a medical devices business.

What multiple did ExcelFin Acquisition Corp. pay for Baird Medical?

19.2x EBITDA and 10.60x revenue, based on disclosed deal value of $370.0M and disclosed financials.

M&A TRANSACTION · 2023

Baird Medical acquired by ExcelFin Acquisition Corp.

$370.0M· 19.2x EBITDA· 10.60x revenue

Target

Baird Medical

Acquirer

ExcelFin Acquisition Corp.

Disclosed financials at time of acquisition

Revenue

$35.0M

EBITDA

$19.3M

Deal Value

$370.0M

EV/EBITDA

19.2x

Context

This $370.0M acquisition of Baird Medical by ExcelFin Acquisition Corp. sits in the medical devices sub-vertical. The 19.2x EBITDA multiple paid in 2023 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Baird Medical acquisition.

Citation: ExitValue.ai. (2023). Baird Medical acquired by ExcelFin Acquisition Corp.. https://exitvalue.ai/deals/baird-medical-acquired-by-excelfin-acquisition-corp-hc-2023-0045